Scott Reents
Director of Finance/CFO at TOBIRA THERAPEUTICS INC
Net worth: 3 M $ as of 2024-04-29
Profile
Mr. Scott T.
Reents is a Chief Financial Officer & Executive Vice President at AbbVie, Inc., a Chief Financial Officer at Tobira Therapeutics, Inc., a President & Director at Allergan, Inc. and a President & Director at Oculeve, Inc. He is on the Board of Directors at Allergan, Inc. and Oculeve, Inc. Mr. Reents was previously employed as a Vice President-Tax by Abbott Laboratories.
He received his undergraduate degree from the University of Nebraska, a graduate degree from the University of Washington and an MBA from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABBVIE, INC.
0.00% | 2024-02-27 | 15,431 ( 0.00% ) | 3 M $ | 2024-04-29 |
Scott Reents active positions
| Companies | Position | Start |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
| ABBVIE INC. | Director of Finance/CFO | 2022-06-22 |
| ALLERGAN, INC. | President | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Former positions of Scott Reents
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Training of Scott Reents
| University of Nebraska | Undergraduate Degree |
| University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 3 |
|---|---|
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Scott Reents
